Inhibition of 5′-UTR RNA Conformational Switching in HIV-1 Using Antisense PNAs

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Parkash, Braham ^a   Ranjan, Atul ^b   Tiwari, Vinod ^b   Gupta, Sharad Kumar ^a   Kaur, Navrinder ^a   Tandon, Vibha ^b  

^a UNIVERSITY OF DELHI   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GENOMIC RNA; GUANINE; PEPTIDE NUCLEIC ACID; POLYADENYLIC ACID; PROTEIN SL1; UNCLASSIFIED DRUG; URIDINE; ANTISENSE OLIGONUCLEOTIDE; BUFFER; HETERODUPLEX; MESSENGER RNA; VIRUS RNA;

5' UNTRANSLATED REGION; ARTICLE; DIMERIZATION; DNA TEMPLATE; GENE SWITCHING; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NONHUMAN; PROTEIN DNA INTERACTION; PROTEIN TARGETING; RNA CONFORMATION; RNA PROCESSING; RNA STABILITY; SIGNAL TRANSDUCTION; THERMODYNAMICS; TRANSCRIPTION INITIATION SITE; CHEMISTRY; CONFORMATION; DNA DENATURATION; DRUG EFFECT; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE MOTIF; NUCLEOTIDE SEQUENCE; RADIATION EXPOSURE; TRANSITION TEMPERATURE; ULTRAVIOLET RADIATION; VIRUS GENOME;

HUMAN IMMUNODEFICIENCY VIRUS 1;

5' UNTRANSLATED REGIONS; BASE SEQUENCE; BUFFERS; DIMERIZATION; GENOME, VIRAL; HIV-1; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; NUCLEIC ACID DENATURATION; NUCLEIC ACID HETERODUPLEXES; NUCLEOTIDE MOTIFS; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDE NUCLEIC ACIDS; RNA, MESSENGER; RNA, VIRAL; TEMPLATES, GENETIC; TRANSITION TEMPERATURE; ULTRAVIOLET RAYS;

EID: 84869013594     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049310     Document Type: Article

References (61)

1. Bender W, Davidson N, (1976) Mapping of poly(A) sequences in the electron microscope reveals unusual structure of type C oncornavirus RNA molecules. Cell 7: 595-607.
2. Hoglund S, Ohagen A, Goncalves J, Panganiban AT, Gabuzda D, (1997) Ultrastructure of HIV-1 genomic RNA. Virology 233: 271-279.
3. Fu W, Rein A, (1993) Maturation of dimeric viral RNA of Moloney murine leukemia virus. J Virol 67: 5443-5449.
4. Darlix JL, Gabus C, Nugeyre MT, Clavel F, Barre-Sinoussi F, (1990) Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J Mol Biol 216: 689-699.
5. Gotte M, Li X, Wainberg MA, (1999) HIV-1 reverse transcription: a brief overview focused on structure-function relationships among molecules involved in initiation of the reaction. Arch Biochem Biophys 365: 199-210.
6. Berkhout B, (1996) Structure and function of the human immunodeficiency virus leader RNA. Prog. Nucleic Acids Res. Mol Biol 54: 1-34.
7. Harrison GP, Lever AM, (1992) The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure. J Virol 66: 4144-4153.
8. Harrison GP, Miele G, Hunter E, Lever AM, (1998) Functional analysis of the core human immunodeficiency virus type 1 packaging signal in a permissive cell line. J Virol 72: 5886-5896.
9. Baudin F, Marquet R, Isel C, Darlix JL, Ehresmann B, et al. (1993) Functional sites in the 5' region of human immunodeficiency virus type 1 RNA form defined structural domains. J Mol Biol 229: 382-397.
10. Huthoff H, Berkhout B, (2001) Two alternating structures of the HIV-1 leader RNA. RNA 7: 143-157.
11. Damgaard CK, Andersen ES, Knudsen B, Gorodkin J, Kjems J, (2004) RNA interactions in the 5' region of the HIV-1 genome. J Mol Biol 336: 369-379.
12. Ooms M, Huthoff H, Russell R, Liang C, Berkhout B, (2004) A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions. J Virol 78: 10814-10819.
13. Abbink TE, Berkhout B, (2003) A novel long distance base-pairing interaction in human immunodeficiency virus type 1 RNA occludes the Gag start codon. J Biol Chem 278: 11601-11611.
14. Paillart JC, Dettenhofer M, Yu XF, Ehresmann C, Ehresmann B, et al. (2004) First snapshots of the HIV-1 RNA structure in infected cells and in virions. J Biol Chem 279: 48397-48403.
15. Song R, Kafaie J, Laughrea M, (2008) Role of the 5' TAR stem-loop and the U5-AUG duplex in dimerization of HIV-1 genomic RNA. Biochemistry 47: 3283-3293.
16. Skripkin E, Paillart JC, Marquet R, Ehresmann B, Ehresmann C, (1994) Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitro. Proc Natl Acad Sci U S A 91: 4945-4949.
17. Paillart JC, Marquet R, Skripkin E, Ehresmann B, Ehresmann C, (1994) Mutational analysis of the bipartite dimer linkage structure of human immunodeficiency virus type 1 genomic RNA. J Biol Chem 269: 27486-27493.
18. Laughrea M, Jette L, (1994) A 19-nucleotide sequence upstream of the 5' major splice donor is part of the dimerization domain of human immunodeficiency virus 1 genomic RNA. Biochemistry 33: 13464-13474.
19. Paillart JC, Skripkin E, Ehresmann B, Ehresmann C, Marquet R, (1996) A loop-loop "kissing" complex is the essential part of the dimer linkage of genomic HIV-1 RNA. Proc Natl Acad Sci U S A 93: 5572-5577.
20. Muriaux D, Fosse P, Paoletti J, (1996) A kissing complex together with a stable dimer is involved in the HIV-1Lai RNA dimerization process in vitro. Biochemistry 35: 5075-5082.
21. Jalalirad M, Laughrea M, (2010) Formation of immature and mature genomic RNA dimers in wild-type and protease-inactive HIV-1: differential roles of the Gag polyprotein, nucleocapsid proteins NCp15, NCp9, NCp7, and the dimerization initiation site. Virology 407: 225-236.
22. Jalalirad M, Saadatmand J, Laughrea M, (2012) Dominant role of the 5' TAR bulge in dimerization of HIV-1 genomic RNA, but no evidence of TAR-TAR kissing during in vivo virus assembly. Biochemistry 51: 3744-3758.
23. Coffin JM, (1979) Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. J Gen Virol 42: 1-26.
24. Abbink TE, Ooms M, Haasnoot PC, Berkhout B, (2005) The HIV-1 leader RNA conformational switch regulates RNA dimerization but does not regulate mRNA translation. Biochemistry 44: 9058-9066.
25. Ooms M, Cupac D, Abbink TE, Huthoff H, Berkhout B, (2007) The availability of the primer activation signal (PAS) affects the efficiency of HIV-1 reverse transcription initiation. Nucleic Acids Res 35: 1649-1659.
26. Vrolijk MM, Harwig A, Berkhout B, Das AT, (2009) Destabilization of the TAR hairpin leads to extension of the polyA hairpin and inhibition of HIV-1 polyadenylation. Retrovirology 6: 13.
27. Vrolijk MM, Ooms M, Harwig A, Das AT, Berkhout B, (2008) Destabilization of the TAR hairpin affects the structure and function of the HIV-1 leader RNA. Nucleic Acids Res 36: 4352-4363.
28. Wilkinson KA, Gorelick RJ, Vasa SM, Guex N, Rein A, et al. (2008) High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across distinct biological states. PLoS Biol 6: e96.
29. Watts JM, Dang KK, Gorelick RJ, Leonard CW, Bess JW Jr, et al. (2009) Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 460: 711-716.
30. Paillart JC, Shehu-Xhilaga M, Marquet R, Mak J, (2004) Dimerization of retroviral RNA genomes: an inseparable pair. Nat Rev Microbiol 2: 461-472.
31. Russell RS, Liang C, Wainberg MA, (2004) Is HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably? Retrovirology 1: 23.
32. Sakuragi J, Ueda S, Iwamoto A, Shioda T, (2003) Possible role of dimerization in human immunodeficiency virus type 1 genome RNA packaging. J Virol 77: 4060-4069.
33. Song R, Kafaie J, Yang L, Laughrea M, (2007) HIV-1 viral RNA is selected in the form of monomers that dimerize in a three-step protease-dependent process; the DIS of stem-loop 1 initiates viral RNA dimerization. J Mol Biol 371: 1084-1098.
34. Paillart JC, Berthoux L, Ottmann M, Darlix JL, Marquet R, et al. (1996) A dual role of the putative RNA dimerization initiation site of human immunodeficiency virus type 1 in genomic RNA packaging and proviral DNA synthesis. J Virol 70: 8348-8354.
35. Berkhout B, van Wamel JL, (1996) Role of the DIS hairpin in replication of human immunodeficiency virus type 1. J Virol 70: 6723-6732.
36. Hill MK, Shehu-Xhilaga M, Campbell SM, Poumbourios P, Crowe SM, et al. (2003) The dimer initiation sequence stem-loop of human immunodeficiency virus type 1 is dispensable for viral replication in peripheral blood mononuclear cells. J Virol 77: 8329-8335.
37. Shen N, Jette L, Liang C, Wainberg MA, Laughrea M, (2000) Impact of human immunodeficiency virus type 1 RNA dimerization on viral infectivity and of stem-loop B on RNA dimerization and reverse transcription and dissociation of dimerization from packaging. J Virol 74: 5729-5735.
38. Shen N, Jette L, Wainberg MA, Laughrea M, (2001) Role of stem B, loop B, and nucleotides next to the primer binding site and the kissing-loop domain in human immunodeficiency virus type 1 replication and genomic-RNA dimerization. J Virol 75: 10543-10549.
39. Laughrea M, Shen N, Jette L, Darlix JL, Kleiman L, et al. (2001) Role of distal zinc finger of nucleocapsid protein in genomic RNA dimerization of human immunodeficiency virus type 1; no role for the palindrome crowning the R-U5 hairpin. Virology 281: 109-116.
40. Balakrishnan M, Roques BP, Fay PJ, Bambara RA, (2003) Template dimerization promotes an acceptor invasion-induced transfer mechanism during human immunodeficiency virus type 1 minus-strand synthesis. J Virol 77: 4710-4721.
41. Clever JL, Miranda D Jr, Parslow TG, (2002) RNA structure and packaging signals in the 5' leader region of the human immunodeficiency virus type 1 genome. J Virol 76: 12381-12387.
42. Laughrea M, Jette L, Mak J, Kleiman L, Liang C, et al. (1997) Mutations in the kissing-loop hairpin of human immunodeficiency virus type 1 reduce viral infectivity as well as genomic RNA packaging and dimerization. J Virol 71: 3397-3406.
43. Skripkin E, Paillart JC, Marquet R, Blumenfeld M, Ehresmann B, et al. (1996) Mechanisms of inhibition of in vitro dimerization of HIV type I RNA by sense and antisense oligonucleotides. J Biol Chem 271: 28812-28817.
44. Lodmell JS, Paillart JC, Mignot D, Ehresmann B, Ehresmann C, et al. (1998) Oligonucleotide-mediated inhibition of genomic RNA dimerization of HIV-1 strains MAL and LAI: a comparative analysis. Antisense Nucleic Acid Drug Dev 8: 517-529.
45. Berkhout B, Ooms M, Beerens N, Huthoff H, Southern E, et al. (2002) In vitro evidence that the untranslated leader of the HIV-1 genome is an RNA checkpoint that regulates multiple functions through conformational changes. J Biol Chem 277: 19967-19975.
46. Turner JJ, Fabani M, Arzumanov AA, Ivanova G, Gait MJ, (2006) Targeting the HIV-1 RNA leader sequence with synthetic oligonucleotides and siRNA: chemistry and cell delivery. Biochim Biophys Acta 1758: 290-300.
47. Egholm M, Buchardt O, Christensen L, Behrens C, Freier SM, et al. (1993) PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature 365: 566-568.
48. Buchardt O, Egholm M, Berg RH, Nielsen PE, (1993) Peptide nucleic acids and their potential applications in biotechnology. Trends Biotechnol 11: 384-386.
49. Bai H, Sang G, You Y, Xue X, Zhou Y, et al. (2012) Targeting RNA polymerase primary sigma70 as a therapeutic strategy against methicillin-resistant Staphylococcus aureus by antisense peptide nucleic acid. PLoS One 7: e29886.
50. Demidov VV, Potaman VN, Frank-Kamenetskii MD, Egholm M, Buchard O, et al. (1994) Stability of peptide nucleic acids in human serum and cellular extracts. Biochem Pharmacol 48: 1310-1313.
51. Agrawal S, Ikeuchi T, Sun D, Sarin PS, Konopka A, et al. (1989) Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues. Proc Natl Acad Sci U S A 86: 7790-7794.
52. Goodchild J, Agrawal S, Civeira MP, Sarin PS, Sun D, et al. (1988) Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides. Proc Natl Acad Sci U S A 85: 5507-5511.
53. Zhang S, Hara H, Kaji H, Kaji A, (1997) Inhibition of HIV type 1 RNA dimerization by antisense DNA corresponding to the 17-nucleotide sequence downstream from the splice donor site of HIV type 1 RNA. AIDS Res Hum Retroviruses 13: 865-873.
54. Elmen J, Zhang HY, Zuber B, Ljungberg K, Wahren B, et al. (2004) Locked nucleic acid containing antisense oligonucleotides enhance inhibition of HIV-1 genome dimerization and inhibit virus replication. FEBS Lett 578: 285-290.
55. Andersen ES, Jeeninga RE, Damgaard CK, Berkhout B, Kjems J, (2003) Dimerization and template switching in the 5' untranslated region between various subtypes of human immunodeficiency virus type 1. J Virol 77: 3020-3030.
56. Paillart JC, Skripkin E, Ehresmann B, Ehresmann C, Marquet R, (2002) In vitro evidence for a long range pseudoknot in the 5'-untranslated and matrix coding regions of HIV-1 genomic RNA. J Biol Chem 277: 5995-6004.
57. Lu K, Heng X, Garyu L, Monti S, Garcia EL, et al. (2011) NMR detection of structures in the HIV-1 5'-leader RNA that regulate genome packaging. Science 334: 242-245.
58. Sakuragi J, Ode H, Sakuragi S, Shioda T, Sato H, (2012) A proposal for a new HIV-1 DLS structural model. Nucleic Acids Res 40: 5012-5022.
59. Muriaux D, Girard PM, Bonnet-Mathoniere B, Paoletti J, (1995) Dimerization of HIV-1Lai RNA at low ionic strength. An autocomplementary sequence in the 5' leader region is evidenced by an antisense oligonucleotide. J Biol Chem 270: 8209-8216.
60. Berkhout B, van Wamel JL, (2000) The leader of the HIV-1 RNA genome forms a compactly folded tertiary structure. RNA 6: 282-295.
61. Berkhout B, Vastenhouw NL, Klasens BI, Huthoff H, (2001) Structural features in the HIV-1 repeat region facilitate strand transfer during reverse transcription. RNA 7: 1097-1114.